Company / Operating Cash Flow per Share
Sagimet Biosciences Inc. Operating Cash Flow per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.27
FY2024
5-year range
-$132.32 / -$2.27
FY2023-FY2024
Trend
+98.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-2.27 in FY2024.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 98.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.27 | +98.3% |
| FY2023 | -$132.32 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026